News | April 09, 2007

New Omega 3 Surgical Mesh from Atrium Medical FDA Cleared

April 10, 2007 - Atrium Medical Corp. has obtained FDA clearance for a new Omega 3 surgical mesh product called C-QURLite Mesh.

This new product is indicated for use in the surgical repair and reinforcement of soft tissue, including hernia repair - a common procedure performed more than 700,000 times in the U.S. each year. This novel technology combines Atrium's ProLite Ultra polypropylene surgical mesh with a proprietary, pharmaceutical grade Omega 3 fatty acid bio-absorbable gel coating. Unlike traditional tissue separating mesh products, C-QURLite Mesh enhances the handling stiffness and healing response in pre-peritoneal placement when compared to other "bare" polymer mesh products currently used for hernia repair.

C-QURLite Mesh is constructed from the refined ProLite Ultra polypropylene monofilament, providing a low profile, strong, lightweight base structure. The novel all natural Omega 3 gel coating is then applied in a proprietary method, coating each monofilament of the mesh to enhance material handling and subsequent healing. This non-polymeric, bio-absorbable coating has demonstrated in pre-clinical studies to significantly improve anatomical conformance by reducing aggressive, dense acellular collagen formation known to induce adhesions following surgery.

Atrium's discovery of combining inert thin wall polypropylene mesh with an Omega 3 biological coating in pre-clinical studies has demonstrated minimization of peritoneal tissue attachment as well as a significant reduction in both foreign body reaction and inflammation, resulting in a well healed, reinforced soft tissue repair. The novel C-QURLite Mesh BAO coating (BioAbsorbable Oil) also enhances ease of handling and tissue plane placement, which subsequently forms into an elegant soft and flexible implant. It offers improved stiffness and handling qualities preferred by many of today's discriminating surgeons while maintaining excellent see-thru visibility to underlying tissue landmarks for improved anatomical orientation during surgical installation.

The use of Atrium's all natural Omega 3 bio-absorbable coating with its advanced lightweight surgical mesh provides today's clinicians with a broad spectrum of options for both laparoscopic and open surgical repair. This first to market BAO coating technology enables cells to freely grow through the porous mesh implant during healing immediately following soft tissue repair. Atrium's C-QURLite Mesh will be available in a wide variety of preferred anatomical laser cut shapes and sizes mid-year 2007.

Related Content

Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
Philips launches Azurion with FlexArm to set new standard for the future of image-guided procedures

Philips launches Azurion with FlexArm to set new standard for the future of image-guided procedures.

News | Radiology Imaging | December 12, 2019
December 12, 2019 — Philips and the Regional Medical Center
Patient Treatments With ViewRay's MRIdian Linac Begin in New England
News | Image Guided Radiation Therapy (IGRT) | October 08, 2019
ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac...
Varian Unveils Ethos Solution for Adaptive Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian...
ASTRO 2019 to Feature Clinical Experience and Patient Outcomes With Viewray MRIdian
News | Image Guided Radiation Therapy (IGRT) | September 11, 2019
ViewRay Inc. announced that the company's MRIdian and MRIdian Linac magnetic resonance imaging (MRI)-guided radiation...
Beamscan MR 3D water phantom – the first 3-D water phantom for magnetic resonance (MR)-guided radiotherapy
News | Radiation Therapy | August 27, 2019
Radiation dosimetry company announced plans to exhibit its full range of radiation therapy dosimetry solutions for...
First Cancer Patient Treated With Accuray Radixact System With Synchrony Motion Tracking
News | Image Guided Radiation Therapy (IGRT) | August 21, 2019
Physicians at the Froedtert & the Medical College of Wisconsin (MCW) Clinical Cancer Center in Milwaukee have...
MD Anderson to Expand Proton Therapy Center

The MD Anderson Proton Therapy Center expansion is expected to be completed in 2023. Rendering courtesy of Stantec.

News | Proton Therapy | August 08, 2019
The University of Texas MD Anderson Cancer Center unveiled plans to expand its Proton Therapy Center during a...